KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Receivables (2020 - 2024)

Historic Receivables for Hims & Hers Health (HIMS) over the last 5 years, with Q4 2024 value amounting to $6.1 million.

  • Hims & Hers Health's Receivables fell 895.52% to $6.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.1 million, marking a year-over-year decrease of 895.52%. This contributed to the annual value of $6.1 million for FY2024, which is 895.52% down from last year.
  • As of Q4 2024, Hims & Hers Health's Receivables stood at $6.1 million, which was down 895.52% from $6.7 million recorded in Q4 2023.
  • Hims & Hers Health's Receivables' 5-year high stood at $6.7 million during Q4 2023, with a 5-year trough of $1.1 million in Q4 2020.
  • Its 5-year average for Receivables is $4.4 million, with a median of $4.1 million in 2021.
  • Its Receivables has fluctuated over the past 5 years, first surged by 27272.73% in 2021, then crashed by 895.52% in 2024.
  • Quarter analysis of 5 years shows Hims & Hers Health's Receivables stood at $1.1 million in 2020, then skyrocketed by 272.73% to $4.1 million in 2021, then fell by 4.88% to $3.9 million in 2022, then skyrocketed by 71.79% to $6.7 million in 2023, then decreased by 8.96% to $6.1 million in 2024.
  • Its Receivables stands at $6.1 million for Q4 2024, versus $6.7 million for Q4 2023 and $3.9 million for Q4 2022.